Drug Shortage Report for NV-CLINDAMYCIN
| Report ID | 268159 |
| Drug Identification Number | 02245832 |
| Brand name | NV-CLINDAMYCIN |
| Common or Proper name | Clindamycin |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CLINDAMYCIN |
| Strength(s) | 150MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2025-08-28 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2025-09-25 |
| Shortage status | Resolved |
| Updated date | 2025-10-01 |
| Company comments | Return to market |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-10-01 | French | Compare |
| v1 | 2025-10-01 | English | Compare |
Showing 1 to 2 of 2